Elsevier

The Lancet

Volume 350, Issue 9075, 9 August 1997, Pages 430-436
The Lancet

Review
Chronic infections and coronary heart disease: is there a link?

https://doi.org/10.1016/S0140-6736(97)03079-1Get rights and content

Summary

A large number of studies have reported on associations of human coronary heart disease (CHD) and certain persistent bacterial and viral infections. We review the epidemiological and clinical evidence on CHD and Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus (CMV), as well as possible mechanisms. The association between CHD and H pylori may be accounted for by residual confounding from risk factors. Although the association between C pneumoniae and CHD is stronger, the sequence of infection and disease is uncertain. As regards CMV, a limited number of patients with classic atherosclerotic coronary artery disease have been studied. Further studies are needed to resolve these uncertainties.

Section snippets

Review methods

Epidemiological and clinical studies published in any language before January, 1997, that reported on associations between the presence of H pylori, C pneumoniae, or CMV and CHD were sought by Medline searches, scanning of relevant reference lists, hand-searching of cardiology, gastroenterology, and other relevant journals, and discussions with various investigators. Combinations of key words were used in the computer searches, including: Helicobacter pylori, Campylobacter pylori, Chlamydia

Epidemiological associations

Since the first report in 1994, at least 20 epidemiological studies of about 2600 cases in total have reported on the association of H pylori antibody titres and either CHD (19 studies) or stroke (Figure 2). The chief difficulty in trying to find out whether a causal association exists is that certain potential confounding factors; of which low socioeconomic status is a general indicator, seem to be strongly associated both with H pylori infection and with CHD (table).

Failure to make

Epidemiological associations

Most of the 18 published epidemiological studies of C pneumoniae antibodies and CHD (or, in two cases, cerebrovascular disease) found at least two-fold or larger odds ratios (figure 3), and some reported increasing odds ratios with increasing antibody titres. The studies were done in different populations, used different criteria for cases, adjusted for potential confounders to differing degrees, and were, therefore, prone to different biases. The general consistency of their findings in a

Epidemiological associations

Two-fold or larger odds ratios have been reported in several epidemiological studies of CMV antibodies and cardiovascular disease (figure 4). Some of these reports described increasing odds ratios with increasing antibody titres or with the severity of the atherosclerosis, which strengthen the plausibility of the associations. However, these studies of CMV, even more than those of H pylori or C pneumoniae, were characterised by small sample sizes, incomplete adjustments for known confounders,

Observational studies

Epidemiological studies of infections and CHD are needed. These studies should be large enough for moderate-sized effects to be assessed or refuted reliably, and involve repeated antibody measurements in at least a subsample to allow correction for regression dilution.3 In such studies, the effects of residual confounders need to be kept to a minimum, for example by investigation of socially homogeneous populations (such as doctors) or age-matched and sex-matched sibling-pairs (one with and one

Conclusion

The available evidence about chronic infections and CHD is still sparse and its interpretation is limited by potential biases. For H pylori, residual confounding by causal risk factors may account entirely for the rather weak epidemiological associations that have been reported. For C pneumoniae, the evidence of association is stronger, but the temporal sequence of infection and CHD is uncertain. For CMV, only a limited number of patients with classic atherosclerotic CHD have been studied. Some

References (60)

  • M Leinonen

    Pathogenetic mechanisms and epidemiology of

    Chlamydia pneumoniae. Eur Heart J

    (1993)
  • SE Epstein et al.

    The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus

    Lancet

    (1996)
  • P Patel et al.

    Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

    BMJ

    (1995)
  • MA Mendall et al.

    C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

    BMJ

    (1996)
  • PM Ridker et al.

    Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

    N Engl J Med

    (1997)
  • D Birnie et al.

    Association between antibodies to mycobacterial heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori in increasing cardiovascular risk

    Heart

    (1996)
  • S Niemela et al.

    Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?

    Heart

    (1996)
  • RKR Scragg et al.

    Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce

    J Epidemiol Commun Health

    (1996)
  • JJY Sung et al.

    Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease

    Heart

    (1996)
  • DG Colin-Jones et al.

    Postmarketing surveillance of the safety of cimetidine: 10 year mortality report

    Gut

    (1992)
  • LJ Murray et al.

    Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class

    Br Heart J

    (1995)
  • EM Ndawula et al.

    Helicobacter pylori bacteraemia

    Eur J Microbiol Infect Dis

    (1994)
  • G Gonzalez-Valencia et al.

    Susceptibility of Helicobacter pylori to the bactericidal activity of human serum

    Helicobacter

    (1996)
  • F Blasi et al.

    Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms

    J Clin Microbiol

    (1996)
  • SP Wang et al.

    Microimmunofluorescence serology in Chlamydia trachomatis

  • CA Gaydos et al.

    Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells

    Infect Immunity

    (1996)
  • LA Campbell et al.

    Mouse models of atherosclerosis and Chlamydia pneumoniae

    Proc Third Eur Soc Chlam Res

    (1996)
  • A Shor et al.

    Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques

    S Afr Med J

    (1992)
  • C Kuo et al.

    Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

    J Infect Dis

    (1993)
  • CC Kuo et al.

    Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain

    Arterioscler Thromb

    (1993)
  • Cited by (1163)

    View all citing articles on Scopus
    View full text